Fundz

Watching VASO CORPORATION? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

VASO CORPORATION

vasocorporation.com
Filed: Jul 23, 2026CIK: 0000839087Health Care
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

VASO Corporation appointed Shaun McMeans as a Class III director on July 23, 2026, bringing extensive CFO experience from life sciences companies. This appointment strengthens the board's financial oversight capabilities and signals a focus on enhanced governance.

Key Takeaways

Shaun McMeans appointed as Class III director effective immediately, bringing CFO experience from Nabsys and HTG Molecular Diagnostics

McMeans will serve on the Board's audit committee, emphasizing financial oversight and governance

1 more takeaway

Filing Overview

Form Type8-K
Filing DateJul 23, 2026
Item5.02
CategoryExecutive Change
CIK0000839087
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board changeleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

VASO CORPORATION filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.